6-3012591-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000904.6(NQO2):c.220G>A(p.Glu74Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E74D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000904.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NQO2 | NM_000904.6 | c.220G>A | p.Glu74Lys | missense_variant | Exon 4 of 7 | ENST00000380455.11 | NP_000895.2 | |
NQO2 | NM_001290221.2 | c.220G>A | p.Glu74Lys | missense_variant | Exon 7 of 10 | NP_001277150.1 | ||
NQO2 | NM_001318940.2 | c.220G>A | p.Glu74Lys | missense_variant | Exon 4 of 7 | NP_001305869.1 | ||
NQO2 | NM_001290222.2 | c.220G>A | p.Glu74Lys | missense_variant | Exon 4 of 6 | NP_001277151.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251456 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727242 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74324 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.220G>A (p.E74K) alteration is located in exon 4 (coding exon 3) of the NQO2 gene. This alteration results from a G to A substitution at nucleotide position 220, causing the glutamic acid (E) at amino acid position 74 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at